The protective effect of α7‐nACh receptor and its interaction with 5‐HT1B/1D receptors in acute intestinal ischemia‐reperfusion injury in rats
Abstract Over the past decades, great attention has been given to the nervous system modulating effects on the immune response in inflammation‐associated injuries, such as acute intestinal ischemia‐reperfusion (IR). Recently, we proved the anti‐inflammatory and antioxidant effects of 5‐hydroxytryptamine (5‐HT)1B/1D receptors in intestinal IR injury in rats. Also, the alpha7 nicotinic acetylcholine (α7‐nACh) receptor has anti‐inflammatory effects in different inflammation‐associated injuries. Starting from these premises, we aimed to examine the function of the α7‐nACh receptors and the functional interactions between the anti‐inflammatory and antioxidant effects of α7‐nACh and 5‐HT1B/1D receptors in acute intestinal IR injury. To confirm the expression and localization of α7‐nACh receptors on the ileum nerves, an immunofluorescence‐based method was applied. Then, intestinal IR injury was induced by 30‐min occlusion of superior mesenteric artery and reperfusion for 2 h in rats. Acute systemic administration of α7‐nACh receptor agonist PNU‐282987 and antagonist methyllycaconitine, and 5‐HT1B/1D receptors agonist (sumatriptan) and antagonist (GR127, 935) were used in the model of intestinal IR injury. Finally, biochemical and histological parameters were assessed. Α7‐nACh receptors were expressed by 9% on the ileum nerves. Likewise, activation of the α7‐nACh receptor showed anti‐inflammatory and antioxidant effects in intestinal IR injury but not as well as 5‐HT1B/1D receptors. Interestingly, 5‐HT1B/1D receptors via attenuation of glutamate (Glu) release indirectly activated the α7‐nACh receptor and its protective effects against inflammation and oxidative stress. The protective effect of the α7‐nACh receptor on intestinal IR injury was activated indirectly through the 5‐HT1B/1D receptors’ modulatory impact on Glu release..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Fundamental & Clinical Pharmacology - 36(2022), 1, Seite 100-113 |
| Beteiligte Personen: |
Gharishvandi, Fatemeh [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2022 John Wiley & Sons, Ltd. |
|---|
| Umfang: |
14 |
|---|
| doi: |
10.1111/fcp.12705 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY005642388 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY005642388 | ||
| 003 | DE-627 | ||
| 005 | 20230307152417.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/fcp.12705 |2 doi | |
| 028 | 5 | 2 | |a FCP_FCP12705.xml |
| 035 | |a (DE-627)WLY005642388 | ||
| 035 | |a (WILEY)FCP12705 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.40 |2 bkl | ||
| 084 | |a 44.38 |2 bkl | ||
| 100 | 1 | |a Gharishvandi, Fatemeh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a The protective effect of α7‐nACh receptor and its interaction with 5‐HT1B/1D receptors in acute intestinal ischemia‐reperfusion injury in rats |
| 264 | 1 | |c 2022 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2022 John Wiley & Sons, Ltd. | ||
| 520 | |a Abstract Over the past decades, great attention has been given to the nervous system modulating effects on the immune response in inflammation‐associated injuries, such as acute intestinal ischemia‐reperfusion (IR). Recently, we proved the anti‐inflammatory and antioxidant effects of 5‐hydroxytryptamine (5‐HT)1B/1D receptors in intestinal IR injury in rats. Also, the alpha7 nicotinic acetylcholine (α7‐nACh) receptor has anti‐inflammatory effects in different inflammation‐associated injuries. Starting from these premises, we aimed to examine the function of the α7‐nACh receptors and the functional interactions between the anti‐inflammatory and antioxidant effects of α7‐nACh and 5‐HT1B/1D receptors in acute intestinal IR injury. To confirm the expression and localization of α7‐nACh receptors on the ileum nerves, an immunofluorescence‐based method was applied. Then, intestinal IR injury was induced by 30‐min occlusion of superior mesenteric artery and reperfusion for 2 h in rats. Acute systemic administration of α7‐nACh receptor agonist PNU‐282987 and antagonist methyllycaconitine, and 5‐HT1B/1D receptors agonist (sumatriptan) and antagonist (GR127, 935) were used in the model of intestinal IR injury. Finally, biochemical and histological parameters were assessed. Α7‐nACh receptors were expressed by 9% on the ileum nerves. Likewise, activation of the α7‐nACh receptor showed anti‐inflammatory and antioxidant effects in intestinal IR injury but not as well as 5‐HT1B/1D receptors. Interestingly, 5‐HT1B/1D receptors via attenuation of glutamate (Glu) release indirectly activated the α7‐nACh receptor and its protective effects against inflammation and oxidative stress. The protective effect of the α7‐nACh receptor on intestinal IR injury was activated indirectly through the 5‐HT1B/1D receptors’ modulatory impact on Glu release. | ||
| 700 | 1 | |a Shafaroodi, Hamed |4 aut | |
| 700 | 1 | |a Mohammad Jafari, Razieh |4 aut | |
| 700 | 1 | |a Abdollahi, Alireza |4 aut | |
| 700 | 1 | |a Pasalar, Parvin |4 aut | |
| 700 | 1 | |a Dehpour, Ahmad Reza |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Fundamental & Clinical Pharmacology |g 36(2022), 1, Seite 100-113 |w (DE-627)WLY005640377 |x 14728206 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2022 |g number:1 |g pages:100-113 |g extent:14 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 44.40 |q ASE |
| 936 | b | k | |a 44.38 |q ASE |
| 951 | |a AR | ||
| 952 | |d 36 |j 2022 |e 1 |h 100-113 |g 14 | ||